Claudia Gallardo
Family Medicine · El Paso, TXNPI 1134773286
Payments from drug & device makers
Across 138 payments — averaging $28.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$650
- AbbVie$550
- Sanofi-aventis U.S. LLC$411
- Amgen$358
- Bayer$325
- Lilly USA, LLC$242
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $650 |
| AbbVie | 22 | $550 |
| Sanofi-aventis U.S. LLC | 14 | $411 |
| Amgen | 11 | $358 |
| Bayer | 14 | $325 |
| Lilly USA, LLC | 14 | $242 |
| Dexcom, Inc. | 6 | $188 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $155 |
| Hologic Sales And Service, LLC | 2 | $116 |
| Cvrx, Inc. | 1 | $104 |
| Radius Health, Inc. | 6 | $102 |
| Novo Nordisk | 5 | $91 |
| Biogen | 1 | $81 |
| Astellas Pharma US Inc | 1 | $81 |
| Johnson & Johnson | 5 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Pfizer | 4 | $70 |
| Boehringer Ingelheim | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Novartis | 2 | $44 |
| GSK | 3 | $43 |
| Neurocrine Biosciences, Inc. | 1 | $34 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Insulet Corporation | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$247
- EVENITY$146
- VRAYLAR$125
- Creon$125
- Kerendia$124
- TOUJEO$123
- AIRSUPRA$122
- DEXCOM G6 TRANSMITTER$116
- SOLIQUA 100/33$108
- Barostim Neo System$104
How this compares
$3,984 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 89 | $136,935 |
| TymlosAbaloparatide | 48 | $122,687 |
| OzempicSemaglutide | 79 | $121,850 |
| MounjaroTirzepatide | 72 | $115,320 |
| FarxigaDapagliflozin Propanediol | 59 | $71,185 |
| JardianceEmpagliflozin | 46 | $65,675 |
| EliquisApixaban | 34 | $42,710 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 18 | $32,027 |
| MyrbetriqMirabegron | 22 | $27,403 |
| SynjardyEmpagliflozin/Metformin Hcl | 20 | $26,484 |
| VascepaIcosapent Ethyl | 37 | $26,348 |
| JanuviaSitagliptin Phosphate | 26 | $23,672 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 17 | $22,410 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $21,521 |
| LinzessLinaclotide | 12 | $13,148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $242 | $252,255161 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Tradjenta | $55 | $137,22895 claims |
| Radius Health, Inc.Tymlos | $102 | $122,68748 claims |
| Novo NordiskOzempic | $91 | $121,85079 claims |
| AstraZenecaFarxiga, Brilinta, Breztri Aerosphere | $650 | $89,25383 claims |
| PfizerEliquis | $70 | $42,71034 claims |
| Astellas Pharma US IncMyrbetriq | $81 | $27,40322 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $411 | $22,41017 claims |
| AbbVieLinzess | $550 | $13,14812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in El Paso
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.